Document is current
Any future updates will be listed below
-
Authors
Rasbach, Erik
Migayron, Laure
Brandenburg, Anne
Singh, Praveen
Martins, Christina
Kassem, Ali
Karkempetzaki, Anastasia I.
Suessner, Nadine
Kulcsar, Zsofi
Riopedre, Jessica
Silva, Mariana
Zhen, Ethan
Xu, Shuyun
Mucciarone, Kyla
Holzgruber, Julia
Williams, Jason B.
Birgin, Emrullah
Levesque, Mitchell P.
Martínez-Gómez, Julia M.
Dummer, Reinhard
Landsberg, Jennifer
Lian, Christine G.
Murphy, George F.
Berdan, Emma L.
Sui, Shannan Ho
Kupper, Thomas S.
Rahbari, Nuh N.
Lee, Nayoung
Barthel, Steven R.
Schatton, Tobias
-
Funding
Funding for this research was provided by:
Walter Benjamin Scholarship from the German Research Foundation (470684420)
POTENTIAL Clinician Scientist Fellowship from the Else-Kroener-Fresenius Foundation
Foreign Exchange Fellowship from the German National Merit Foundation
Carl Duisberg Fellowship from the Bayer Foundation
Dermatology Fellowship Award from the Melanoma Research Alliance
Klaus-Wolff Fellowship from the Austrian Society of Dermatology and Venereology
Marietta Blau-Grant from Austria’s Agency for Education and Internationalization
BioBank Core Facility of the University Hospital Bonn, Germany
NIH/NCI grant (R01CA247957)
NIH/NCI grant (R01CA247957)
NIH/NCI grant (R01CA190838)
Medical Student Grant from the American Skin Association
Dermatology Foundation
Milstein Research Scholar Award from the American Skin Association
Fund to Sustain Research Excellence from the Brigham Research Institute, Brigham and Women’s Hospital
- License Information
-
More Information
Article History
Received: 3 June 2025
Accepted: 9 November 2025
First Online: 18 December 2025
Declarations
:
: All studies involving human specimens were approved by Institutional Review Boards of Mass General Brigham, the University of Zurich, Switzerland, and the University of Bonn, Germany. All studies involving animal experiments were approved by BWH Institutional Animal Care and Use Committee (IACUC).
: Not applicable.
: R.D. is a consultant for Novartis, Merck Sharp & Dohme (MSD), Bristol-Myers Squibb (BMS), Roche, Amgen, Takeda, Pierre Fabre, Sun Pharma, Sanofi, Catalym, Second Genome, Regeneron, Alligator, T3 Pharma, MaxiVAX SA, Pfizer, Simcere, and touchIME, not related to the submitted work. All other authors declare that no competing interests exist.
